These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 19900518

  • 1. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 2. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS, Lu Q, Li W, Chen Y.
    Int J Pharm; 2011 Sep 15; 416(1):16-24. PubMed ID: 21356291
    [Abstract] [Full Text] [Related]

  • 3. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C, Khela MK, Evans DF, Jones BE, Nagata S, Basit AW.
    Eur J Pharm Sci; 2007 Mar 15; 30(3-4):251-5. PubMed ID: 17188473
    [Abstract] [Full Text] [Related]

  • 4. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Mar 15; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 5. "Performance qualification of a new hypromellose capsule. Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules and Part II. Disintegration and dissolution comparison between two types of hypromellose capsules" by M. Sherry Ku et al.
    Jones BE, Podczeck F.
    Int J Pharm; 2012 Feb 28; 423(2):589-92. PubMed ID: 22155286
    [No Abstract] [Full Text] [Related]

  • 6. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Feb 28; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 7. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct 28; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 8. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010 Oct 28; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 9. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer.
    Li DX, Yan YD, Oh DH, Yang KY, Seo YG, Kim JO, Kim YI, Yong CS, Choi HG.
    Drug Deliv; 2010 Jul 28; 17(5):322-9. PubMed ID: 20367177
    [Abstract] [Full Text] [Related]

  • 10. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M, Rothenhäusler B, Röthlisberger D.
    Drug Dev Ind Pharm; 2006 Jul 28; 32(10):1165-73. PubMed ID: 17090439
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET, Scott RA, Cade D, Connor AL, Wilding IR.
    Pharm Res; 2004 May 28; 21(5):793-8. PubMed ID: 15180336
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
    Honkanen O, Laaksonen P, Marvola J, Eerikäinen S, Tuominen R, Marvola M.
    Eur J Pharm Sci; 2002 Jun 28; 15(5):479-88. PubMed ID: 12036724
    [Abstract] [Full Text] [Related]

  • 13. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 14. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N, Hennia I, Ecenarro S, Amighi K.
    Int J Pharm; 2018 Dec 20; 553(1-2):47-56. PubMed ID: 30321640
    [Abstract] [Full Text] [Related]

  • 15. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE, Basit AW, Tuleu C.
    Int J Pharm; 2012 Mar 15; 424(1-2):40-3. PubMed ID: 22214655
    [Abstract] [Full Text] [Related]

  • 16. The shell dissolution of various empty hard capsules.
    Chiwele I, Jones BE, Podczeck F.
    Chem Pharm Bull (Tokyo); 2000 Jul 15; 48(7):951-6. PubMed ID: 10923822
    [Abstract] [Full Text] [Related]

  • 17. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G, Cadé D, Benameur H, Weitschies W.
    Eur J Pharm Sci; 2014 Jun 16; 57():264-72. PubMed ID: 24021609
    [Abstract] [Full Text] [Related]

  • 18. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC, Podczeck F, Turnbull N.
    Int J Pharm; 2004 Nov 05; 285(1-2):51-63. PubMed ID: 15488679
    [Abstract] [Full Text] [Related]

  • 19. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET, Cadé D, Benameur H.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):747-56. PubMed ID: 18096270
    [Abstract] [Full Text] [Related]

  • 20. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
    Koehl NJ, Shah S, Tenekam ID, Khamiakova T, Sauwen N, Vingerhoets S, Coppenolle H, Holm R.
    Pharm Res; 2021 Aug 17; 38(8):1439-1454. PubMed ID: 34378150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.